Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy.
about
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesUltrasound microbubbles combined with liposome-mediated pNogo-R shRNA delivery into neural stem cells.An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cellsMesenchymal stem cells at the intersection of cell and gene therapy.Cationic liposome-mediated CXCR4 gene delivery into hematopoietic stem/progenitor cells: implications for clinical transplantation and gene therapy.Magnetofection Mediated Transient NANOG Overexpression Enhances Proliferation and Myogenic Differentiation of Human Hair Follicle Derived Mesenchymal Stem Cells.Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivoGlucocorticoid Cell Priming Enhances Transfection Outcomes in Adult Human Mesenchymal Stem Cells.Delivering factors for reprogramming a somatic cell to pluripotencyVirus-mimetic cytoplasm-cleavable magnetic/silica nanoclusters for enhanced gene delivery to mesenchymal stem cellsIn vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives.Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.Non-viral gene therapy for bone tissue engineering.Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells.Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.An EBV-based plasmid can replicate and maintain in stem cells.A comparative study of non-viral gene delivery techniques to human adipose-derived mesenchymal stem cell.Direct head-to-head comparison of cationic liposome-mediated gene delivery to mesenchymal stem/stromal cells of different human sources: a comprehensive studyEffective gene delivery into human stem cells with a cell-targeting Peptide-modified bioreducible polymer.Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis.A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells.A simple protocol for transfecting human mesenchymal stem cells.Dual non-viral gene delivery from microparticles within 3D high-density stem cell constructs for enhanced bone tissue engineering.Nonviral gene targeting at rDNA locus of human mesenchymal stem cells.
P2860
Q26777286-1C71B10E-4D1B-47EC-A31F-091780CD2BBAQ26850868-FEC1240E-BA87-4F54-B4E5-A006B3DA3D77Q30416174-A82AE76D-9F91-4EC8-995E-E197B0F000C2Q33790771-7891D341-C921-4A25-A15D-85798826B240Q34676808-05BDEFCC-3F7D-4A81-9193-B95CCF92DCFDQ36036499-F9234736-6A56-44F6-8BB7-EDC96DE9F982Q36225105-00B12795-2A30-4F88-99DA-7E09C2DE0C21Q36360773-3377B66E-9D9A-4DA9-9AFB-72F20FB49DA7Q36756853-0C4A4CD1-0802-426C-B111-D9CF6B0B27D9Q37344004-8377AF62-9455-4CCB-B957-0200A9A21DBBQ37352200-4B0D7818-59D6-4DC0-B703-2B588D517391Q37850449-8AC69573-1B23-497C-A7CF-926FBAB0CEC1Q38181868-2F74BD78-2906-429F-8A5C-A229274731A6Q38191018-455D36B7-551D-47A8-9DA5-A9C5B2C6D9EAQ38691354-358A7D09-1690-4F47-A9FC-A937297C1E88Q38825691-BC66E291-FF21-4F9E-8C94-7A2233B4C916Q38844765-54D6D902-B4F8-4D51-9CD6-94D2FB5C51CBQ38962413-F0670D36-D0CB-4753-B07F-0AA1A62AE834Q39407951-639A4C62-DC1F-4EF5-9B88-74D1A455804CQ41595503-40D79BF3-B578-41E6-89C6-AC9EA7638EE6Q42057790-E9C03894-CE37-4758-A300-0B4CB8B3C1A7Q42322592-5269A686-D9C8-4D7A-B58B-D223B59413E9Q47552051-EC850C9A-C0DC-4260-8333-98831DD440B4Q50110952-62A26B23-07C2-44ED-9C09-BA343AB589FFQ51872343-13BD56EC-2C96-4279-869C-113CC1F6AF7D
P2860
Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Nonviral gene delivery to mese ...... mes for gene and cell therapy.
@en
type
label
Nonviral gene delivery to mese ...... mes for gene and cell therapy.
@en
prefLabel
Nonviral gene delivery to mese ...... mes for gene and cell therapy.
@en
P2093
P2860
P356
P1476
Nonviral gene delivery to mese ...... mes for gene and cell therapy.
@en
P2093
C L da Silva
J M S Cabral
M R Aires-Barros
R D Mendes
S C Ribeiro
P2860
P304
P356
10.1155/2010/735349
P577
2010-06-24T00:00:00Z